±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 168  |  »Ø¸´: 0
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

CZD1972

°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

[½»Á÷] GMPÎļþ³£¼ûËõд

ABPI Association of the British Pharmaceutical Industry
ADR Adverse Drug Reaction
AE Adverse Event
AIM Active Ingredient Manufacturer
ANDA Abbreviated New Drug Application
ANOVA Analysis of Variance
ASM: Active Substance Manufacturer
ATC Anatomical Therapeutic Chemical
ATX Animal Test Exemption Certificate
BAN British Approved Name
BIRA British Institute of Regulatory Affairs
BNF British National Formulary
BP British Pharmacopoeia
C of A Certificate of Analysis
C of S Certificate of Suitability
CENTRE FOR DRUG EVALUATION (CDE)
Centre for Pharmaceutical Administration (CPA)
CMS Concerned Member State
CMSÿ¸ö³ÉÔ±¹ú
COS Certificate of Suitability
CPMP Committee for Proprietary Medicinal Products
CRA Clinical Research Associate
CRF Case Report Form
CRO Contract Research Organisation
CTA Clinical Trial Application
CTC Clinical Trial Certificate
CTD Common Technical Document
CTX Clinical Trials Exemption
DDD Defined Daily Dose
DGC Daily Global Comparison
DIA Drug Information Association
DMF Drug Master File
Drug Registration Branch (DRB), Product Evaluation & Registration Division, CPA
EDQM (European Directorate for the Quality of Medicines) Å·ÖÞÁªÃËÒ©Æ·ÖÊÁ¿Ö¸µ¼Î¯Ô±»á
EEA Å·ÖÞ¾­¼ÃµØÇø
EGMA   European Generics Medicine Association
ELA Established Licence Application
EMEA European Medicines Evaluation Agency
EMEA £¨European Agency for the Evaluation of Medicinal Products£© Å·ÖÞÁªÃËÒ©Æ·ÆÀ¼Û»ú¹¹
EP European Pharmacopoeia
EPAR European Public Assessment Reports
ESRA European Society of Regulatory Affairs
European Pharmacopoeia Commission Å·ÖÞÒ©µäίԱ»á
FDA
FDA   Food and Drug Administration
final evaluation report (FER)
free sale certificates (FSCs)
GCP   Good Clinical Practice
GCPÒ©Æ·ÁÙ´²Ñо¿¹ÜÀí¹æ·¶
GLP Good Laboratory Practice
GLP Ò©Æ·ÁÙ´²Ç°°²È«ÐÔÑо¿ÖÊÁ¿¹ÜÀí¹æ·¶
GMP   Good Manufacturing Practice
GMP Ò©Æ·Éú²úÖÊÁ¿¹ÜÀí¹æ·¶
GSPÒ©Æ·ÏúÊÛ¹ÜÀí¹æ·¶
Health Sciences Authority (HSA)
HSA¡¯s Medicines Advisory Committee (MAC)
IB   Investigators Brochure
ICH International Conference for Harmonisation   
IDMC   Independent Data-Monitoring Committee
IEC Independent Ethics Committee
IND Investigational New Drug   
INN   International Non-proprietary Name   
International Conference on Harmonisation (ICH)
IPC   In Process Control
IRB Institutional Review Board
LICENCE HOLDER
MA   Marketing Authorisation
MAA Marketing Authorisation Application   
MAAÉÏÊÐÉêÇë
MAH   Marketing Authorisation Holder
MAH ÏúÊÛÐí¿É³ÖÓÐÕß
MCA   Medicines Control Agency   
MHW Ministry of Health and Welfare (Japan)
MR   Mutual Recognition
MRA ÃÀ¹úÓëÅ·Ã˵Ļ¥ÈÏЭÒé
MRAs (Mutual Recognition Agreements) »¥ÏàÕJ×CͬÒâ
MRFG Mutual Recognition Facilitation Group
MRP Mutual Recognition Procedure   
NAS New Active Substance   
NCE New Chemical Entity   
NDA New Drug Application   
new chemical entities (NCEs)
new drug applications (NDAs)
NSAID   Non Steroidal Anti Inflammatory Drug   
NTA Notice To Applicants
OOS Out of Specification
OTC Over The Counter   
PAGB Proprietary Association of Great Britain   
Ph Eur European Pharmacopoeia   
PIL   Patient Information Leaflet
PL Product Licence   
POM Prescription Only Medicine   
PRODUCT OWNER
PSU Periodic Safety Updates   
QA Quality Assurance   
QC Quality Control   
RAJ Regulatory Affairs Journal   
RMS Reference Member State   
RMSÏ໥ÈÏ¿ÉÁíÒ»³ÉÔ±¹ú
RSD Relative Standard Deviation   
Rx Prescription Only   
SAE Serious Adverse Event   
SMF Site Master File
SOP Standard Operating Procedure   
SOP £¨STANDARD OPERATION PROCEDURE£© ±ê×¼ÔË×÷³ÌÐò
SPC/SmPC Summary of Product Characteristics   
summary of product characteristics(SPC)
Therapeutic Goods Administration (TGA)
USP US Pharmacopoeia   
VMF Veterinary Master File   
VPC Veterinary Products Committee
»Ø¸´´ËÂ¥
ÕôÆû½ÚÄÜ¡¢½ÚÄÜÉ豸¼°³¬ÖØÁ¦Çëµ½ÎÒµÄÍøÕ¾ÌÖÂÛ£ºhttp://www.jngc.net.cn/
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ CZD1972 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] µ÷¼ÁÉêÇë +7 ÕÅÕÅÕÅÕÅzy 2026-03-31 7/350 2026-03-31 22:25 by piaoyi415
[¿¼ÑÐ] 334·Ö Ò»Ö¾Ô¸ÎäÀí-080500 ²ÄÁÏÇóµ÷¼Á +10 ÀîÀî²»·þÊä 2026-03-25 10/500 2026-03-31 21:20 by yuq
[¿¼ÑÐ] Ò»Ö¾Ô¸»ª¶«Àí¹¤´óѧ£¬080500ѧ˶£¬317·Ö£¬Çóµ÷¼Á +9 s1145 2026-03-31 9/450 2026-03-31 18:47 by JourneyLucky
[¿¼ÑÐ] 336²ÄÁÏÇóµ÷¼Á +10 ³ÂäÞÓ¨ 2026-03-26 12/600 2026-03-31 17:59 by jp9609
[¿¼ÑÐ] 285Çóµ÷¼Á +3 FZAC123 2026-03-30 3/150 2026-03-31 17:49 by ÈÈÇéɳĮ
[¿¼ÑÐ] Çóµ÷¼Á +9 akdhjs 2026-03-31 10/500 2026-03-31 17:14 by zhyzzh
[¿¼ÑÐ] ÉúÎïѧ296Çóµ÷¼Á +8 ÌÀÔ²°ü 2026-03-29 12/600 2026-03-31 17:05 by 18828373951
[¿¼ÑÐ] 315Çóµ÷¼Á +6 akie... 2026-03-28 7/350 2026-03-31 16:48 by asdfzly
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ìµ÷¼Á +13 ÉîVËÞÉá°É 2026-03-30 14/700 2026-03-31 16:28 by hypershenger
[¿¼ÑÐ] ²ÄÁÏÓ뻯¹¤272Çóµ÷¼Á +25 °¢Ë¹µÙ·Ò2004 2026-03-28 25/1250 2026-03-31 16:27 by hypershenger
[¿¼ÑÐ] 347Çóµ÷¼Á +11 ɽ¶¥¼û¦Á 2026-03-25 11/550 2026-03-31 14:14 by ¼Çʱ¾2026
[¿¼ÑÐ] ±¾¿Æ211°²È«¹¤³Ì£¬³õÊÔ290·Ö£¬Çóµ÷¼Á +3 2719846834 2026-03-28 3/150 2026-03-31 13:52 by ÈÈÇéɳĮ
[¿¼ÑÐ] һ־ԸʳƷ¿ÆÑ§Ó빤³Ì083200Çóµ÷¼Á +4 XQTJZ 2026-03-30 4/200 2026-03-31 04:10 by fmesaito
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©»¯¹¤´óѧ²ÄÁÏÓ뻯¹¤£¨085600£©296Çóµ÷¼Á +25 µ¾ÆÞС±à 2026-03-26 25/1250 2026-03-30 20:11 by µÎµÎÉϰ¶Ñ½
[¿¼ÑÐ] 322Çóµ÷¼Á +10 ËÎÃ÷ÐÀ 2026-03-27 10/500 2026-03-30 18:47 by 544594351
[¿¼ÑÐ] ҩѧ105500Çóµ÷¼Á +3 Ssun¡£¡£ 2026-03-28 3/150 2026-03-28 11:24 by lxf170613
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[¿¼ÑÐ] µ÷¼Á +3 Àî¼Îͼ¡¤S¡¤Â· 2026-03-27 3/150 2026-03-27 11:19 by wangjy2002
[¿¼ÑÐ] 341Çóµ÷¼Á +7 ÇàÄûÃÊ1 2026-03-26 7/350 2026-03-27 00:19 by wxiongid
[¿¼ÑÐ] 303Çóµ÷¼Á +6 À¶É½Ô 2026-03-25 6/300 2026-03-25 22:47 by 418490947
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û